References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Hechleretal(2005)Inhibitionofplateletfunctionsandthrombosisthroughselectiveornon-selectiveinhibitionoftheplateletP2receptorswithincreasingdosesofNF449[4,4',4",4'"-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzeJ.Pharmacol.Exp.Ther.314232PMID:15792995
Hoheneggeretal(1998)Gsα-selectiveGproteinantagonists.Proc.Natl.Acad.Sci.U.S.A.95346PMID:9419378
Rettingeretal(2005)ProfilingatrecombinanthomomericandheteromericratP2XreceptorsidentifiesthesuraminanalogueNF449asahighlypotentP2X1receptorantagonist.Neuropharmacology.48461PMID:15721178
Flemingetal(2011)Chemicalmodulatorsofautophagyasbiologicalprobesandpotentialtherapeutics.Nat.Chem.Biol.79PMID:21164513
Keywords:NF449,supplier,selective,P2X1,antagonists,Receptors,Purinergic,purinoceptors,NF449,P2X,Receptors,Autophagy,P2X,Receptors,TocrisBioscience